Loading chat...

RI S2855

Bill

Status

Introduced

3/4/2026

Primary Sponsor

Pamela Lauria

Click for details

Origin

Senate

2026 Regular Session

AI Summary

  • Students diagnosed with asthma, bronchospasm conditions, or anaphylaxis may possess and self-administer inhaled asthma medications or auto-injectable/intranasal epinephrine during school hours, at school-sponsored activities, and on school buses with parental consent and physician documentation.

  • Every school must stock undesignated emergency supplies including at least two doses each of: nasal/injectable glucagon, FDA-approved rescue inhalers, valved holding chambers, and nasal/auto-injector epinephrine.

  • School teachers, administrators, healthcare personnel, bus drivers, bus monitors, and other trained school staff may administer these emergency medications to any student believed to be experiencing anaphylaxis, bronchospasm, asthma symptoms, or hypoglycemia.

  • School personnel who administer these medications are granted immunity from civil liability for ordinary negligence, though immunity does not extend to gross negligence or willful/wanton conduct.

  • Effective date: January 1, 2027.

Legislative Description

Permits students diagnosed with asthma, a condition that may lead to bronchospasm or anaphylaxis, or both, to carry and self-administer asthma medication or auto-injectable or intranasal epinephrine, or both.

Education

Last Action

Committee recommended measure be held for further study

3/10/2026

Committee Referrals

Health and Human Services3/4/2026

Full Bill Text

No bill text available